A1ZN34:BVMF
Astrazeneca Plc Bdr
144,14 R$
0,00%
(0,00) 1D
25 սեպ, 16:56:00 GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1ZN34...
Open
142,68 R$
High
144,14 R$
Low
142,68 R$
Mkt. cap
257,28 մլրդ
Avg. vol.
489,00
Volume
764,00
52-wk high
190,40 R$
52-wk low
130,02 R$
Shares outstanding
1,55 մլրդ
No. of employees
96 հզր
Open
142,68 R$
High
144,14 R$
Low
142,68 R$
Mkt. cap
257,28 մլրդ
Avg. vol.
489,00
Volume
764,00
52-wk high
190,40 R$
52-wk low
130,02 R$
Shares outstanding
1,55 մլրդ
No. of employees
96 հզր
News stories
From web sources and news partners
Traders Union
·
17 ժամ առաջ
AstraZeneca chief buys shares as trial setbacks weigh on sentiment
TipRanks
·
23 ժամ առաջ
AstraZeneca Updates Real‑World Kidney Cancer Study in China, Offering Fresh Clues for Oncology Investors
Stock Titan
·
1 օր առաջ
AstraZeneca IMFINZI combo gets FDA Priority Review | AZN Stock News
Traders Union
·
1 օր առաջ
Can European Commission approval for Trixeo Aerosphere support AstraZeneca stock?
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About Astrazeneca Plc Bdr
CEOPascal Soriot
Employees96,1 հզր
Founded06 ապր, 1999 թ.
HeadquartersՔեմբրիջ, Cambridgeshire, Միացյալ Թագավորություն
Sector-
Websiteastrazeneca.com